Drug intelligence / Profile preview

Zhizhen Fang

Development stage: Unknown
Lead developer: Shanghai General Hospital
Administration: Oral

Overview

Zhizhen Fang (also known as Zhizhen Recipe) is a Traditional Chinese Medicine (TCM) herbal formula developed by researchers at Shanghai General Hospital. It is primarily utilized as an adjuvant therapy in combination with standard chemotherapy (such as the XELOX regimen) for patients with stage III colorectal cancer. The formula is designed to improve clinical outcomes by reversing multidrug resistance (MDR) and mitigating the toxic side effects associated with chemotherapy. Clinical investigations focus on its ability to enhance the sensitivity of cancer cells to chemotherapeutic agents and improve the overall quality of life and survival rates of patients post-surgery.

Other names: Zhizhen RecipeZhizhen Formula

Targets

Autophagy (Autophagy machinery (ATG family))

Beyond the preview

Go deeper on Zhizhen Fang.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Zhizhen Fang.

Explore the full profile